The Aenova Group publishes Annual Report 2022

Starnberg, 01/08/2023

The Aenova Group publishes its 2022 Annual Report today.

The key figures 2022 of Aenova at a glance:

  • € 749 million Net Sales 2022
  • € 107 million adjusted EBITDA
  • + 22% Order book

"We continued to expand our capacities to allow for future growth and continue to grow our technology offering to increase our competitiveness in the market," said Jan Kengelbach, CEO of Aenova Group. "We inaugurated a full new aseptic manufacturing facility for high-speed PFS and vial filling including large molecule fill and finish. Our new high-speed, large volume solid plant expansion in Tittmoning went online, and we continued to build our expansions in Kirchberg for softgel capsule packaging. We made good progress in Carugate building a high-speed liquids and semi-solid manufacturing or in Regensburg establishing a future high-potent manufacturing to come online in 2024 and 2025 respectively. This strategy of capacity expansion and capability extension through the introduction of new technologies and superior development service offering continues to serve us very well”, Jan Kengelbach added.

Despite an increased revenue by +7.5% from EUR 697 m to EUR 749 m, the EBITDA declined from EUR 107 m to EUR 97 m by 9%. Future perimeter adjusted for the closure of the site in Wolfratshausen, the business grew by 10% from EUR 651 m to EUR 714 m, while EBITDA declined by 2% from EUR 104 m to EUR 102 m.

Learn more about Aenova's 2022 achievements and milestones, as well as key events in each business unit.

Read more.